| domain | curated finding | evidence type/strength | suggested ontology terms |
|---|---|---|---|
| Disease identity | **Rh deficiency syndrome** is a rare inherited red-cell membrane disorder characterized by absent or markedly reduced Rh antigen expression with membrane instability and chronic hemolysis; disease mapping available as **MONDO:0019107**. Data are derived from aggregated disease literature and rare individual case reports/series rather than EHR-scale cohorts. (pqac-00000000, pqac-00000006) | Moderate: disease-level ontology mapping plus review literature; limited by rarity | MONDO:0019107; UBERON:0000178 blood; CL:0000232 erythrocyte |
| Synonyms / serologic terms | Common names include **Rh deficiency syndrome**, **Rh-null syndrome**, **Rhnull phenotype**, and **Rhmod syndrome** (for regulator-type reduced/modified Rh expression due to RHAG defects). (pqac-00000000) | Moderate: established transfusion/genetic nomenclature in foundational literature curated through disease-target evidence | MONDO:0019107 |
| Genetic etiology | Two classical molecular classes are recognized: **regulator type** caused by **RHAG** defects, and **amorph type** caused by defects in **RHD/RHCE** leading to absence of Rh antigens. Open Targets disease associations support **RHAG**, **RHCE**, and **RHD** for Rh deficiency syndrome. (pqac-00000000, pqac-00000003) | Strong for gene-disease association: curated human genetic evidence; strongest for RHAG | HGNC:9881 RHAG; HGNC:10009 RHD; HGNC:10008 RHCE |
| Inheritance | The core **Rh-null syndrome** is typically **autosomal recessive** in both regulator-type RHAG deficiency and amorph-type combined RH gene defects. Distinguish from **overhydrated hereditary stomatocytosis due to RHAG gain-of-function**, which is often autosomal dominant and is related but not equivalent disease biology. (pqac-00000000, pqac-00000003, pqac-00000005) | Moderate: consistent with foundational case literature and membrane-disorder reviews; some mechanistic overlap with RHAG-related stomatocytosis | HP:0000007 Autosomal recessive inheritance; HP:0000006 Autosomal dominant inheritance (differential/related RHAG disorder) |
| Core pathophysiology | RhAG is a membrane glycoprotein in the **Rh complex** with Rh proteins and associated proteins; the complex interacts with the membrane skeleton directly/indirectly via **ankyrin R**, **CD47**, **protein 4.2**, **band 3**, and glycophorin B. Loss of the complex reduces red-cell deformability and shortens erythrocyte survival. (pqac-00000003, pqac-00000006) | Strong for membrane-complex biology from reviews and experimental systems | GO:0005886 plasma membrane; GO:0016021 integral component of membrane; GO:0008092 cytoskeletal protein binding; GO:0006814 sodium ion transport; GO:0015696 ammonium transport |
| Protein / transport function | **RHAG** functions as an **ammonium and/or CO2 channel** in erythrocytes; altered RhAG or absent Rh complex disrupts membrane transport and hydration homeostasis, contributing to stomatocytic morphology and hemolysis. (pqac-00000003) | Moderate: supported by yeast/oocyte functional studies summarized in review literature | GO:0015696 ammonium transport; GO:0015701 bicarbonate transport; CHEBI:28938 ammonium; CHEBI:16526 carbon dioxide |
| Primary anatomy | The principal affected structure is the **erythrocyte plasma membrane / red-cell membrane skeleton** rather than a parenchymal organ. (pqac-00000005, pqac-00000006) | Strong for anatomic localization from red-cell membrane reviews | CL:0000232 erythrocyte; UBERON:0000178 blood; GO:0005886 plasma membrane; GO:0005925 focal adhesion/membrane-cytoskeleton interface (approximate) |
| Cellular players | Main cell type affected is the **mature erythrocyte**; reticulocytes are involved as a laboratory correlate of compensatory erythropoiesis. (pqac-00000002, pqac-00000006) | Strong for erythrocyte involvement; moderate for reticulocyte emphasis | CL:0000232 erythrocyte; CL:0000558 reticulocyte |
| Clinical phenotype: hemolytic anemia | Typical presentation is **chronic congenital hemolytic anemia** due to shortened RBC survival. (pqac-00000005, pqac-00000006) | Moderate to strong: consistent across membrane-disorder reviews; disease-specific frequency unavailable | HP:0001878 Hemolytic anemia; HP:0001890 Chronic hemolytic anemia |
| Clinical phenotype: stomatocytosis | **Stomatocytes** on peripheral smear are a classic morphological clue in Rh deficiency / RhAG-related membrane disease. (pqac-00000003, pqac-00000005) | Moderate: morphology well established, but percentage varies and disease-specific frequency unavailable | HP:0004446 Stomatocytosis |
| Clinical phenotype: reticulocytosis | **Reticulocytosis** is expected as a compensatory response to chronic hemolysis. (pqac-00000002, pqac-00000004) | Moderate: inferred from hemolysis workup and stomatocytosis review | HP:0001923 Reticulocytosis |
| Clinical phenotype: macrocytosis | **Macrocytosis / elevated MCV** is commonly reported in overhydrated stomatocytic phenotypes related to Rh membrane dysfunction and may be part of Rh-deficiency presentations. (pqac-00000004, pqac-00000005) | Moderate: stronger for RHAG/OHS-related membrane disease than for all Rh-null cases | HP:0005518 Increased mean corpuscular volume; HP:0001407 Macrocytosis |
| Clinical phenotype: jaundice / hyperbilirubinemia | Chronic hemolysis can produce **jaundice** and **hyperbilirubinemia**, including neonatal presentations in severe congenital hemolytic states. (pqac-00000002, pqac-00000004) | Moderate: broad hereditary hemolysis evidence; disease-specific rates unavailable | HP:0000952 Jaundice; HP:0002904 Increased total bilirubin |
| Clinical phenotype: splenomegaly | **Splenomegaly** is reported in many chronic hemolytic anemias and may occur in Rh deficiency syndrome as part of extravascular hemolysis. (pqac-00000005) | Limited to moderate: extrapolated from hereditary membrane hemolysis literature; disease-specific primary frequency unavailable | HP:0001744 Splenomegaly; UBERON:0002106 spleen |
| Clinical phenotype: gallstones | **Pigment gallstones/cholelithiasis** are recognized complications of chronic hemolysis and may occur in Rh deficiency syndrome. (pqac-00000005) | Limited to moderate: complication known for congenital hemolytic anemia; disease-specific frequency unavailable | HP:0001081 Cholelithiasis; UBERON:0002110 gallbladder |
| Clinical phenotype: iron overload | **Secondary iron overload/hemosiderosis** can develop in chronic hemolytic anemias even with limited transfusion exposure. (pqac-00000004) | Moderate for hereditary stomatocytosis/hemolytic anemia literature; Rh-deficiency-specific prevalence unavailable | HP:0003281 Hemosiderosis; HP:0003236 Increased serum ferritin |
| Disease course / onset | Usually **congenital** or recognized from childhood, with a **chronic lifelong** course of variable severity. (pqac-00000004, pqac-00000005) | Moderate: natural-history pattern consistent, but large longitudinal cohorts absent | HP:0003577 Congenital onset; HP:0011463 Childhood onset |
| Serology / laboratory identity | Diagnostic hallmark is **Rh-null or Rhmod serology** with absent or markedly reduced Rh antigen expression on red cells; standard hemolysis workup often shows anemia, increased reticulocytes, hyperbilirubinemia, low haptoglobin, and elevated LDH. (pqac-00000000, pqac-00000002) | Strong for serologic identity; moderate for ancillary labs in disease-specific cases | LOINC/SNOMED concept suggestion: Rh blood group typing; HP:0001972 Decreased haptoglobin level; HP:0003151 Increased LDH level |
| Peripheral blood morphology | Peripheral smear may show **stomatocytes** and other hemolysis-related red-cell shape abnormalities; anemia is commonly macrocytic in overhydrated states. (pqac-00000003, pqac-00000005) | Moderate | HP:0004446 Stomatocytosis; HP:0001877 Abnormal erythrocyte morphology |
| Functional membrane testing | **Osmotic gradient ektacytometry** is considered the best diagnostic technique for red-cell membrane transport disorders, though availability is limited. Indirect tests include osmotic fragility/Pink test/AGLT where relevant. (pqac-00000004, pqac-00000005) | Moderate to strong for membrane-disorder diagnosis; disease-specific use supported by overlap with stomatocytic phenotypes | NCIT: C120675 Osmotic Fragility Test (approximate); diagnostic procedure concept: ektacytometry |
| Genetic testing | Recommended molecular approach is **targeted NGS / red-cell membrane disorder panel** including **RHAG**, and if Rh-null serology is present, evaluation of **RHD/RHCE**. Broader exome/genome testing may be useful in unresolved cases. (pqac-00000004, pqac-00000000) | Moderate: review-based recommendation; no disease-specific trial data | NCIT: C84351 Genetic Testing; HGNC:9881 RHAG; HGNC:10009 RHD; HGNC:10008 RHCE |
| Differential diagnosis | Key differentials include other **hereditary stomatocytoses**, **hereditary spherocytosis**, **dehydrated hereditary stomatocytosis/xerocytosis**, and other congenital hemolytic anemias. (pqac-00000005, pqac-00000006) | Strong for class-level differential diagnosis | MONDO suggestions: hereditary stomatocytosis; hereditary spherocytosis |
| Treatment: supportive care | Management is largely **supportive**: folate/B12 supplementation when indicated, transfusion for severe anemia/aplastic crises, neonatal phototherapy if hyperbilirubinemic, and iron chelation if overload develops. (pqac-00000004) | Moderate: based on hereditary stomatocytosis/hemolytic anemia management reviews; no Rh-deficiency-specific controlled trials | NCIT: C156818 Supportive Care; NCIT: C25179 Blood Transfusion; NCIT: C15313 Phototherapy; NCIT: C15784 Iron Chelation Therapy |
| Treatment: splenectomy caution | **Splenectomy should generally be avoided/used with extreme caution** in overhydrated/dehydrated hereditary stomatocytic disorders because of ineffectiveness and thromboembolic risk; this principle is commonly extended when Rh-deficiency presents within this membrane-transport phenotype spectrum. (pqac-00000004, pqac-00000005) | Moderate: strong for HSt spectrum, indirect for classical Rh-null syndrome | NCIT: C17173 Splenectomy; HP:0001907 Thromboembolism |
| Transfusion medicine | Patients have major **rare-blood transfusion challenges**; if transfusion is required, **Rh-null-compatible units** or carefully selected rare-donor blood are needed, making advance transfusion planning essential. (pqac-00000000) | Moderate: well established in rare-donor literature; few modern case series | NCIT: C25179 Blood Transfusion; rare donor registry concept |
| Prevention / counseling | No primary environmental prevention is known; **genetic counseling**, family studies, carrier testing in affected pedigrees, and rare-donor registry linkage are the main preventive/public-health measures. (pqac-00000004, pqac-00000000) | Moderate | NCIT: C15709 Genetic Counseling |
| Epidemiology | **Population prevalence, incidence, sex ratio, and carrier frequency are not robustly established** because Rh deficiency syndrome is exceptionally rare and reported mainly through single cases/families. Explicit frequency estimates should therefore be marked **unavailable** rather than inferred. (pqac-00000000) | Strong for evidence gap: rarity is clear; quantitative rates unavailable | epidemiology field: unavailable/not established |
| Evidence limitations | Much of the literature mixes **classical Rh-null syndrome** with related **RHAG-associated overhydrated stomatocytosis/Rhmod** phenotypes; ontology curation should preserve this distinction while linking shared membrane-pathobiology. (pqac-00000003, pqac-00000005) | Strong curator note based on cross-source synthesis | curation note; MONDO cross-reference candidate |


*Table: This ontology-ready table summarizes the highest-yield curated facts for Rh deficiency syndrome, including genetics, phenotypes, anatomy, diagnosis, and supportive management. It is designed to support disease knowledge-base curation while explicitly marking where epidemiologic frequencies remain unavailable.*